IASO Bio
PrivateLast Round
Series C
Extension
Sep 1, 2025
Total Funding Raised
$303.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
IASO Bio is a biopharmaceutical company that develops innovative cell therapies and biologics for the treatment of hematological malignancies and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IASO Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
IASO Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Sep 1, 2025 | ||||
| Strategic | Jul 5, 2024 | ||||
| Series C Extension | Jan 17, 2023 | ||||
| Series C | Sep 16, 2021 | ||||
| Series B | Mar 24, 2020 | ||||
Series A | Oct 1, 2019 |
IASO Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hongcheng Capital | Series C Extension |
| CDH Investments | Series C |
| CNCB Investment | Series C |
| CDH Baifu | Series C |
| Hillhouse Investment | Series B, Series A |
| Housen Care Brothers | Series C Extension |
| CCB International | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
Partnered with Instituto Butantan to expand access in Brazil.
- Oct 29, 2025
Partnered with GC Cell to enter the Korean market.
IASO Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IASO Bio's valuation, stock price, and market status.